| Trillium Care Group Llc | |
|
500 Elm Grove Rd Suite 100 Elm Grove WI 53122 | |
| (262) 782-2090 | |
| (262) 782-2092 |
| Full Name | Trillium Care Group Llc |
|---|---|
| Speciality | Social Worker |
| Location | 500 Elm Grove Rd, Elm Grove, Wisconsin |
| Authorized Official Name and Position | Teresa C Ortiz (CLINICAL DIRECTOR PSYCHOTHERAPIST) |
| Authorized Official Contact | 2627822090 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Trillium Care Group Llc 500 Elm Grove Rd Suite 100 Elm Grove WI 53122 Ph: (262) 782-2090 | Trillium Care Group Llc 500 Elm Grove Rd Suite 100 Elm Grove WI 53122 Ph: (262) 782-2090 |
| NPI Number | 1477629640 |
|---|---|
| Provider Enumeration Date | 11/28/2006 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 7618935529 |
|---|---|
| Medicare Enrollment ID | O20041223000193 |
News Archive
During a public health crisis like the COVID-19 pandemic, U.S. hospitals need to allocate scarce medical resources in an equitable manner, according to clinicians and ethicists at the University of Miami Miller School of Medicine.
A Singapore led study has shown that Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radically modify the way that HBV vertical infection of neonates (mother-to-child) is portrayed, and present a paradigm shift in the approach to treatment of patients with chronic hepatitis B.
The study by scientists at the Institute of Cancer Research found that tranylcypromine (TCP) – which can be used to treat psychotic depressive states - can make cancer cells vulnerable to the effects of a vitamin A-derivative drug called ATRA.
Valeant Pharmaceuticals International, Inc., announced today that it has agreed to acquire Afexa Life Sciences Inc. for approximately C$76 million.
Research experts in the epigenetic field from Epigentek have developed a new, breakthrough approach for the identification of the "sixth DNA base," 5-hydroxymethylcytosine (5-hmC). This technology is based on a high throughput, strip-well format and is also incorporated into the first commercially available product, the MethylFlash(TM) Hydroxymethylated DNA Quantification Kit, for rapidly quantifying hydroxymethylated DNA.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477629640 | NPI | - | NPPES |
| 42238700 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 2564 (Wisconsin) | Primary |
| 1041C0700X | Social Worker - Clinical | 2564 (Wisconsin) | Primary |
| Provider Name | Cecilia Teresa Ortiz |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1417007493 PECOS PAC ID: 0547241309 Enrollment ID: I20040527000150 |
News Archive
During a public health crisis like the COVID-19 pandemic, U.S. hospitals need to allocate scarce medical resources in an equitable manner, according to clinicians and ethicists at the University of Miami Miller School of Medicine.
A Singapore led study has shown that Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radically modify the way that HBV vertical infection of neonates (mother-to-child) is portrayed, and present a paradigm shift in the approach to treatment of patients with chronic hepatitis B.
The study by scientists at the Institute of Cancer Research found that tranylcypromine (TCP) – which can be used to treat psychotic depressive states - can make cancer cells vulnerable to the effects of a vitamin A-derivative drug called ATRA.
Valeant Pharmaceuticals International, Inc., announced today that it has agreed to acquire Afexa Life Sciences Inc. for approximately C$76 million.
Research experts in the epigenetic field from Epigentek have developed a new, breakthrough approach for the identification of the "sixth DNA base," 5-hydroxymethylcytosine (5-hmC). This technology is based on a high throughput, strip-well format and is also incorporated into the first commercially available product, the MethylFlash(TM) Hydroxymethylated DNA Quantification Kit, for rapidly quantifying hydroxymethylated DNA.
› Verified 7 days ago
| Provider Name | Lucia M Micheli |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770633752 PECOS PAC ID: 1254399165 Enrollment ID: I20050120000618 |
News Archive
During a public health crisis like the COVID-19 pandemic, U.S. hospitals need to allocate scarce medical resources in an equitable manner, according to clinicians and ethicists at the University of Miami Miller School of Medicine.
A Singapore led study has shown that Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radically modify the way that HBV vertical infection of neonates (mother-to-child) is portrayed, and present a paradigm shift in the approach to treatment of patients with chronic hepatitis B.
The study by scientists at the Institute of Cancer Research found that tranylcypromine (TCP) – which can be used to treat psychotic depressive states - can make cancer cells vulnerable to the effects of a vitamin A-derivative drug called ATRA.
Valeant Pharmaceuticals International, Inc., announced today that it has agreed to acquire Afexa Life Sciences Inc. for approximately C$76 million.
Research experts in the epigenetic field from Epigentek have developed a new, breakthrough approach for the identification of the "sixth DNA base," 5-hydroxymethylcytosine (5-hmC). This technology is based on a high throughput, strip-well format and is also incorporated into the first commercially available product, the MethylFlash(TM) Hydroxymethylated DNA Quantification Kit, for rapidly quantifying hydroxymethylated DNA.
› Verified 7 days ago
| Provider Name | Maribeth A Sadie |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1932259942 PECOS PAC ID: 0345208252 Enrollment ID: I20050121000016 |
News Archive
During a public health crisis like the COVID-19 pandemic, U.S. hospitals need to allocate scarce medical resources in an equitable manner, according to clinicians and ethicists at the University of Miami Miller School of Medicine.
A Singapore led study has shown that Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radically modify the way that HBV vertical infection of neonates (mother-to-child) is portrayed, and present a paradigm shift in the approach to treatment of patients with chronic hepatitis B.
The study by scientists at the Institute of Cancer Research found that tranylcypromine (TCP) – which can be used to treat psychotic depressive states - can make cancer cells vulnerable to the effects of a vitamin A-derivative drug called ATRA.
Valeant Pharmaceuticals International, Inc., announced today that it has agreed to acquire Afexa Life Sciences Inc. for approximately C$76 million.
Research experts in the epigenetic field from Epigentek have developed a new, breakthrough approach for the identification of the "sixth DNA base," 5-hydroxymethylcytosine (5-hmC). This technology is based on a high throughput, strip-well format and is also incorporated into the first commercially available product, the MethylFlash(TM) Hydroxymethylated DNA Quantification Kit, for rapidly quantifying hydroxymethylated DNA.
› Verified 7 days ago
| Provider Name | Jennifer E Foro |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1952416034 PECOS PAC ID: 6002824711 Enrollment ID: I20060322000272 |
News Archive
During a public health crisis like the COVID-19 pandemic, U.S. hospitals need to allocate scarce medical resources in an equitable manner, according to clinicians and ethicists at the University of Miami Miller School of Medicine.
A Singapore led study has shown that Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radically modify the way that HBV vertical infection of neonates (mother-to-child) is portrayed, and present a paradigm shift in the approach to treatment of patients with chronic hepatitis B.
The study by scientists at the Institute of Cancer Research found that tranylcypromine (TCP) – which can be used to treat psychotic depressive states - can make cancer cells vulnerable to the effects of a vitamin A-derivative drug called ATRA.
Valeant Pharmaceuticals International, Inc., announced today that it has agreed to acquire Afexa Life Sciences Inc. for approximately C$76 million.
Research experts in the epigenetic field from Epigentek have developed a new, breakthrough approach for the identification of the "sixth DNA base," 5-hydroxymethylcytosine (5-hmC). This technology is based on a high throughput, strip-well format and is also incorporated into the first commercially available product, the MethylFlash(TM) Hydroxymethylated DNA Quantification Kit, for rapidly quantifying hydroxymethylated DNA.
› Verified 7 days ago
| Provider Name | David F Timmer |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1639286552 PECOS PAC ID: 9436242195 Enrollment ID: I20070911000691 |
News Archive
During a public health crisis like the COVID-19 pandemic, U.S. hospitals need to allocate scarce medical resources in an equitable manner, according to clinicians and ethicists at the University of Miami Miller School of Medicine.
A Singapore led study has shown that Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radically modify the way that HBV vertical infection of neonates (mother-to-child) is portrayed, and present a paradigm shift in the approach to treatment of patients with chronic hepatitis B.
The study by scientists at the Institute of Cancer Research found that tranylcypromine (TCP) – which can be used to treat psychotic depressive states - can make cancer cells vulnerable to the effects of a vitamin A-derivative drug called ATRA.
Valeant Pharmaceuticals International, Inc., announced today that it has agreed to acquire Afexa Life Sciences Inc. for approximately C$76 million.
Research experts in the epigenetic field from Epigentek have developed a new, breakthrough approach for the identification of the "sixth DNA base," 5-hydroxymethylcytosine (5-hmC). This technology is based on a high throughput, strip-well format and is also incorporated into the first commercially available product, the MethylFlash(TM) Hydroxymethylated DNA Quantification Kit, for rapidly quantifying hydroxymethylated DNA.
› Verified 7 days ago
| Provider Name | Monica Jean Maniaci |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1467931931 PECOS PAC ID: 5698149870 Enrollment ID: I20230330001151 |
News Archive
During a public health crisis like the COVID-19 pandemic, U.S. hospitals need to allocate scarce medical resources in an equitable manner, according to clinicians and ethicists at the University of Miami Miller School of Medicine.
A Singapore led study has shown that Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radically modify the way that HBV vertical infection of neonates (mother-to-child) is portrayed, and present a paradigm shift in the approach to treatment of patients with chronic hepatitis B.
The study by scientists at the Institute of Cancer Research found that tranylcypromine (TCP) – which can be used to treat psychotic depressive states - can make cancer cells vulnerable to the effects of a vitamin A-derivative drug called ATRA.
Valeant Pharmaceuticals International, Inc., announced today that it has agreed to acquire Afexa Life Sciences Inc. for approximately C$76 million.
Research experts in the epigenetic field from Epigentek have developed a new, breakthrough approach for the identification of the "sixth DNA base," 5-hydroxymethylcytosine (5-hmC). This technology is based on a high throughput, strip-well format and is also incorporated into the first commercially available product, the MethylFlash(TM) Hydroxymethylated DNA Quantification Kit, for rapidly quantifying hydroxymethylated DNA.
› Verified 7 days ago
News Archive
During a public health crisis like the COVID-19 pandemic, U.S. hospitals need to allocate scarce medical resources in an equitable manner, according to clinicians and ethicists at the University of Miami Miller School of Medicine.
A Singapore led study has shown that Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radically modify the way that HBV vertical infection of neonates (mother-to-child) is portrayed, and present a paradigm shift in the approach to treatment of patients with chronic hepatitis B.
The study by scientists at the Institute of Cancer Research found that tranylcypromine (TCP) – which can be used to treat psychotic depressive states - can make cancer cells vulnerable to the effects of a vitamin A-derivative drug called ATRA.
Valeant Pharmaceuticals International, Inc., announced today that it has agreed to acquire Afexa Life Sciences Inc. for approximately C$76 million.
Research experts in the epigenetic field from Epigentek have developed a new, breakthrough approach for the identification of the "sixth DNA base," 5-hydroxymethylcytosine (5-hmC). This technology is based on a high throughput, strip-well format and is also incorporated into the first commercially available product, the MethylFlash(TM) Hydroxymethylated DNA Quantification Kit, for rapidly quantifying hydroxymethylated DNA.
› Verified 7 days ago
Christos Ministries Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12970 W Bluemound Rd, Suite 105, Elm Grove, WI 53122 Phone: 262-787-2904 Fax: 262-787-2909 | |
Prisma Wellness, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13500 Watertown Plank Rd Ste 102, Elm Grove, WI 53122 Phone: 206-785-1015 Fax: 206-785-1023 | |
Dr. Ann Lawrence, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12900 Lee Ct, Elm Grove, WI 53122 Phone: 414-431-3344 Fax: 414-434-1950 | |
Moonlit Path Behavioral Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13500 Watertown Plank Rd Ste 102, Elm Grove, WI 53122 Phone: 414-867-4318 Fax: 414-404-3623 | |
American Behavioral Clinics Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15285 Watertown Plank Rd, Elm Grove, WI 53122 Phone: 262-797-2818 Fax: 262-797-2814 | |
Jir Psychiatry Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13500 Watertown Plank Rd, #102, Elm Grove, WI 53122 Phone: 262-794-3076 Fax: 949-655-2632 | |
Acs Consulting Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 820 Brinsmere Drive, Elm Grove, WI 53122 Phone: 262-993-5427 |